Cita APA

Williford, S. E., Libby, C. J., Ayokanmbi, A., Otamias, A., Gordillo, J. J., Gordon, E. R., . . . Hjelmeland, A. B. (2021). Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells. PLoS One.

Citación estilo Chicago

Williford, Sarah E., et al. "Novel Dopamine Receptor 3 Antagonists Inhibit the Growth of Primary and Temozolomide Resistant Glioblastoma Cells." PLoS One 2021.

Cita MLA

Williford, Sarah E., et al. "Novel Dopamine Receptor 3 Antagonists Inhibit the Growth of Primary and Temozolomide Resistant Glioblastoma Cells." PLoS One 2021.